SCHEMBL2171752

SCHEMBL2171752

O=P(O)(O)c1ccc(P(=O)(O)O)cc1

nearest known ligand 0.71

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.71
CA4 P22748 1/20 0.71
CA5A P35218 1/20 0.71
TSHR P16473 2/20 0.48
LMNA P02545 1/20 0.48
MEN1 O00255 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C19 P33261 1/20 0.42
KMT2A Q03164 1/20 0.42
TDP1 Q9NUW8 2/20 0.39
CFTR P13569 1/20 0.39
ALDH1A1 P00352 1/20 0.39
PGK1 P00558 4/20 0.38
PGK2 P07205 4/20 0.38
HPGD P15428 1/20 0.36
ALOX15 P16050 1/20 0.36
ESR1 P03372 1/20 0.36
GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4953765 0.90 CA2 (0.60) CA2CA4CA5ATSHRLMNA
SCHEMBL22999982 0.90 CA2 (0.60) CA2CA4CA5ATSHRLMNA
SCHEMBL915277 0.87 CA2 (0.57) CA2CA4CA5ATSHRLMNA
SCHEMBL12313514 0.85 CA2 (0.55) CA2CA4CA5ATSHRLMNA
SCHEMBL1567573 0.85 CA2 (0.55) CA2CA4CA5ATSHRLMNA
SCHEMBL3361462 0.85 CA2 (0.55) CA2CA4CA5ATSHRLMNA
SCHEMBL1828823 0.85 CA2 (0.55) CA2CA4CA5ATSHRLMNA
SCHEMBL3247756 0.85 CA2 (0.55) CA2CA4CA5ATSHRLMNA
SCHEMBL7670089 0.85 CA2 (0.55) CA2CA4CA5ATSHRLMNA
SCHEMBL13713762 0.85 CA2 (0.55) CA2CA4CA5ATSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 211 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260125559-A1 SINGLE-CRYSTAL METAL-FREE HELICAL COVALENT POLYMERS UNIV CITY HONG KONG (HK) 2026-05-07 US claimed
US-12516263-B2 Compositions for reducing friction or stiction of a surface, methods and articles comprising the same ACTNANO, INC. (US) 2026-01-06 US claimed
EP-4665801-A1 COMPOSITIONS FOR REDUCING FRICTION OR STICTION OF A SURFACE, METHODS AND ARTICLES COMPRISING THE SAME Actnano, Inc. (US) 2025-12-24 EP claimed
US-20250279246-A1 Solid Electrolytic Capacitor with Improved ESR and Leakage KEMET ELECTRONICS CORPORATION 2025-09-04 US claimed
CN-119570050-A Chromium phosphonate metal organic framework material and solvent-free preparation method and application thereof 天津工业大学 2025-03-07 CN claimed
WO-2024237137-A1 QUANTUM DOT COMPOSITION, RESIN COMPOSITION, AND WAVELENGTH CONVERSION MATERIAL 信越化学工業株式会社 2024-11-21 WO claimed
US-20240279564-A1 COMPOSITIONS FOR REDUCING FRICTION OR STICTION OF A SURFACE, METHODS AND ARTICLES COMPRISING THE SAME ACTNANO, INC. 2024-08-22 US claimed
WO-2024173535-A1 COMPOSITIONS FOR REDUCING FRICTION OR STICTION OF A SURFACE, METHODS AND ARTICLES COMPRISING THE SAME ACTNANO, INC. (US) 2024-08-22 WO claimed
CN-118179447-A Modified mineral, preparation method, regeneration method and application thereof 中国科学院赣江创新研究院 2024-06-14 CN claimed
WO-2024116801-A1 QUANTUM DOT COMPOSITION, RESIN COMPOSITION USING SAME AND WAVELENGTH CONVERSION MATERIAL 信越化学工業株式会社 2024-06-06 WO claimed
CN-114797494-A Composite membrane crosslinked in situ by metal ion-organic acid complex, preparation and application 华中科技大学 2022-07-29 CN claimed
EP-4017940-A1 METAL-ORGANIC FRAMEWORK CATALYSTS AND THEIR USE IN CATALYTIC CRACKING ExxonMobil Research and Engineering Company (US) 2022-06-29 EP claimed
CN-110997856-B Polishing liquid and polishing method 昭和电工材料株式会社 2021-10-29 CN claimed
CN-112591806-A Method for recovering and regenerating anode active material of waste lithium ion battery 中南大学 2021-04-02 CN claimed
EP-0736539-B1 Mesoporous crystalline acid composition of a diphosphonate-phosphite of a tetravalent metal which can be used as a catalyst ENITECNOLOGIE SPA (IT) 2000-12-20 EP claimed
US-5892080-A Mesoporous crystalline acid composition of a diphosphonate-phosphite of a tetravalent metal which can be used as a catalyst ENIRICERCHE S.P.A. (IT) 1999-04-06 US claimed
EP-0736539-A2 Mesoporous crystalline acid composition of a diphosphonate-phosphite of a tetravalent metal which can be used as a catalyst ENIRICERCHE S.p.A. (IT) 1996-10-09 EP claimed
EP-0469682-B1 Mesoporous crystalline compound of a tetravalent metal ENIRICERCHE SPA (IT) 1994-12-14 EP claimed
US-5166380-A MESOPOROUS CRYSTALLINE SOLID COMPOUND OF A DIPHOSPHONATE/PHOSPHITE OF A TETRAVALENT METAL, WITH A NARROW DISTRIBUTION OF MESOPORES ENIRICERCHE S.P.A. (IT) 1992-11-24 US claimed
EP-0469682-A1 Mesoporous crystalline compound of a tetravalent metal ENIRICERCHE S.p.A. (IT) 1992-02-05 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260125559-A1 SINGLE-CRYSTAL METAL-FREE HELICAL COVALENT POLYMERS TPR, POF1B, TEC CA2 413/4885CA4 288/4885CA5A 1265/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.